- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03570463
GLA:D® Back: Patient Education and Exercises for Self-management of Back Pain
GLA:D® Back: Implementation of Group-based Patient Education and Exercises to Support Self-management of Back Pain
The GLA:D Back project evaluates the implementation of standardised patient education and exercise therapy for people with persistent or recurrent low back pain (LBP) in a hybrid implementation-effectiveness design. This involves evaluating the process of implementation as well as clinician level outcomes and patient level outcomes.
GLA:D (Good Life with OsteoArthritis in Denmark) is a non-profit initiative and registered trademark from the University of Southern Denmark. It educates clinicians in delivering evidence-based care for musculoskeletal health conditions and registers outcomes in a clinical registry. GLA:D Back uses only the acronym.
The main activity of the implementation strategy is a two-days course for physiotherapists and chiropractors in delivering patient education and exercise therapy that is aimed at supporting patient self-management of LBP. This comes with ready-to-use patient education materials and exercise programs. The course is targeted at chiropractors and physiotherapists, but any health care provider authorised to treat patients with back pain in Denmark can participate, i.e. medical doctors, physiotherapists and chiropractors.
The clinical intervention is a group-based program consisting of two sessions of patient education and 8 weeks of supervised exercises. The program uses a cognitive-behavioural approach and the aim of the exercise component is to restore the patient's ability and confidence to move freely. Clinicians decide which patients are offered the program.
The implementation process is evaluated in a dynamic process monitoring the penetration, adoption and fidelity of the clinical intervention.
The education of clinicians is evaluated via clinician-level outcomes concerning attitudes towards back pain and confidence in managing people with LBP.
The clinical intervention and potential effect mechanisms are evaluated at the patient-level in an observational design. Patients who are participating in the GLA:D Back program are followed using measures of knowledge, skills, beliefs, performance, self-efficacy and success in self-management.
Effects at a national level will be investigated via data from national registries of health care utilisation and sick-leave. Patient- and clinician reported data are collected in a registry.
Study Overview
Detailed Description
The clinician training courses are open to all interested authorised back pain clinicians practicing in Denmark. The study evaluates courses conducted in 2018 which involves one or two courses for clinicians in each of five Danish regions.
The adoption of GLA:D Back is investigated by measuring the extent to which clinicians who have participated in the GLA:D Back course conduct the program in their clinics. Reach of the patient target group is determined by asking clinicians about the degree to which patients offered the treatment accept this. Fidelity with the program is investigated quantitatively by asking about treatment content and recall of key messages via patient questionnaires, and by ensuring that patients' individual goals are registered. The quality of care in terms of delivering the key elements of the intervention will be further explored qualitatively.
The profile of patients enrolled in the GLA:D Back programme will be compared between clinics and administrative regions.
Clinician level effects are investigated in an observational longitudinal design with clinician reported data collected before the clinician training course, immediately after the course and 4 months later, and with patient-reported information on delivery collected at their three-months follow up. Indicators of implementation are registration of patients in the GLA:D Back registry and that patients report receiving the educational components of care and supervised exercises. Orientation towards treatment of LBP and confidence in managing patients with LBP are evaluated by clinicians' answers to standardised questionnaires.
Patient level outcomes are aimed at investigating changes in knowledge, beliefs and skills related to the LBP condition which is hypothesized to lead to improved self-efficacy. The initial measures are related to knowledge skills, beliefs and performance, the next line of outcomes to self-efficacy, then daily activities and quality of life and last health care utilisation and work ability.
The compliance with the program is evaluated by patient report of the number of patient education sessions and exercise sessions attended.
The registry is delivered by Odense Patient data Explorative Network (OPEN) at University of Southern Denmark and uses REDCap (Vanderbilt University) as the platform for data collection. Clinicians are registered when signing up for the GLA:D Back course and agreeing to participate in research. Patients are registered by the clinician and have links to patient questionnaires sent to their email before beginning the GLA:D Back program and after 3, 6 and 12 months if consenting to their data being used for research.
Rather than testing effects on one primary outcome, the study evaluates the implementation process and a number of outcomes based on a logical model of change.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Alice Kongsted, PhD
- Phone Number: +4565504531
- Email: akongsted@health.sdu.dk
Study Contact Backup
- Name: Jan Hartvigsen, PhD
- Phone Number: +4565504522
- Email: jhartvigsen@health.sdu.dk
Study Locations
-
-
-
Odense, Denmark, 5230
- Recruiting
- University of Southern Denmark (central unit)
-
Contact:
- Alice R Kongsted, PhD
- Phone Number: +4565504531
- Email: akongsted@health.sdu.dk
-
Contact:
- Anne Marie Rosager
- Email: gladryg@sdu.dk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
The decision to invite a patient to participate in the GLA:D Back program is at the discretion of the clinician. Clinicians are taught that the program was developed for people with persistent or recurrent low back pain and a need for improved self-management
Exclusion Criteria:
Back pain related to specific spinal or systemic pathology, signs of acute nerve root involvement
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
GLA:D Back
Two 1-hour group sessions of patient education 8 weeks of twice-weekly 1-hour supervised group exercise sessions
|
The intervention aims at improving the participant's ability to self-manage low back pain (LBP).
The content is based on a cognitive behavioural approach aimed at supporting pain self-efficacy.
An individual session at the beginning and the end of the group sessions involve goal-setting and physical tests.
Key messages of the patient education include that pain is not a sign of danger and back pain is explained using a behavioural model of (im)balance between demands and capacity rather than emphasising tissue damage.
The exercises aim at restoring natural variation in movement and provides guidance for patients in exploring movement rather than teaching exercises in only one correct manner.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Brief Illness Perceptions Questionnaire (B-IPQ)
Time Frame: Change from baseline to 3 months
|
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause.
Each of the items 1 to 8 are scored 0 - 10.
If internal consistency allows so a sum score is calculated (0-80).
Cause is registered as text.
|
Change from baseline to 3 months
|
Fear Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Change from baseline to 3 months
|
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
|
Change from baseline to 3 months
|
The Arthritis Self-efficacy (ASES)
Time Frame: Change from baseline to 6 months
|
ASES subscales of pain and other symptoms.
Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
|
Change from baseline to 6 months
|
Quality of Life (General health)
Time Frame: Proportions in response categories baseline to 12 months
|
The 36-Item Short Form Health Survey (SF-36 item1); 5-point likert scale
|
Proportions in response categories baseline to 12 months
|
Quality of Life (Social functioning)
Time Frame: Change from baseline to 12 months
|
The 36-Item Short Form Health Survey (SF-36) subdomain social functioning, transformed score 0-100
|
Change from baseline to 12 months
|
Quality of Life (Mental functioning)
Time Frame: Change from baseline to 12 months
|
The 36-Item Short Form Health Survey (SF-36) subdomain mental functioning, transformed score 0-100
|
Change from baseline to 12 months
|
General Health
Time Frame: Change from baseline to 12 months
|
Health thermometer from Eq-5D, score 0= worst imaginable to 100= best imaginable
|
Change from baseline to 12 months
|
Health care visits primary care
Time Frame: During 12 months after participation
|
Number of primary care visits from national registries
|
During 12 months after participation
|
Health care visits hospital
Time Frame: During 12 months after participation
|
Number of hospital visits due to LBP from national registries
|
During 12 months after participation
|
Imaging
Time Frame: During 12 months after participation
|
x-rays, MRI and CT-scans of lower back from national registries
|
During 12 months after participation
|
Pain medication
Time Frame: During 12 months after participation
|
Prescriptions of pain medication from national registries
|
During 12 months after participation
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Confidence with exercises
Time Frame: Change from baseline to 3 months
|
How confident are you in performing exercises in a beneficial way?' (0-10 scale from 'not confident at all' to 'absolutely confident')
|
Change from baseline to 3 months
|
Self-assessed physical capacity
Time Frame: Change from baseline to 3 months
|
Self-assessed physical fitness visual analogue scales on perceived strength, endurance, flexibility, balance, and moving unhindered as compared with that of other people of the same age and sex.
Each item is scored on a 9-point scale (1 = poor; 5 = average; 9 = super).
Each item is treated as one subscale
|
Change from baseline to 3 months
|
Satisfaction with care
Time Frame: 3 months
|
Overall satisfaction with care (5-point Likert scale; 0 = Not at all satisfied, 5 = Extremely satisfied)
|
3 months
|
Patient reported harms or side effects
Time Frame: 3 months
|
Text description of any side effects or problems experienced in relation to the participation in GLA:D Back.
|
3 months
|
Oswestry Disability Index
Time Frame: Change from baseline to 3, 6, 12 months
|
Ten items, sum score 0 - 50 recalculated to 0-100 (0 = No disability; 100 = Maximum disability)
|
Change from baseline to 3, 6, 12 months
|
Pain Intensity
Time Frame: Change from baseline to 3, 6, 12 months
|
Numeric Rating Scale 0-10 for typical back pain last week (0 = no pain; 10 = worst imaginable pain)
|
Change from baseline to 3, 6, 12 months
|
Work ability
Time Frame: During 12 months after participation
|
Number of days off work after 1 month of absenteeism available from the 'DREAM' registry from the Danish Ministry of Employment
|
During 12 months after participation
|
Brief Illness Perceptions Questionnaire (B-IPQ)
Time Frame: Change from baseline to 6, 12 months
|
Nine items covering the constructs of consequences, timeline (expectations of prognosis), personal control, treatment control, identity (extent of symptoms), coherence (understanding of symptoms), emotional representation, concerns, and cause.
Each of the items 1 to 8 are scored 0 - 10.
If internal consistency allows so a sum score is calculated (0-80).
Cause is registered as text.
|
Change from baseline to 6, 12 months
|
Fear Avoidance Beliefs Questionnaire (FABQ)
Time Frame: Change from baseline to 6, 12 months
|
FABQ physical activity subscale (0 = no fear avoidance beliefs; 24 = highest possible fear avoidance)
|
Change from baseline to 6, 12 months
|
The Arthritis Self-efficacy (ASES)
Time Frame: Change from baseline to 3, 12 months
|
ASES subscales of pain and other symptoms.
Each item is scored on a 0 - 10 scale (0 = very uncertain; 10 = very certain)
|
Change from baseline to 3, 12 months
|
Quality of Life (General Health)
Time Frame: Proportions in response categories baseline to 3, 6 months
|
The 36-Item Short Form Health Survey (SF-36 item 1),5-point Likert scale
|
Proportions in response categories baseline to 3, 6 months
|
Quality of Life (Social functioning)
Time Frame: Change from baseline to 3, 6 months
|
The 36-Item Short Form Health Survey (SF-36) subdomains social functioning, transformed score 0-100
|
Change from baseline to 3, 6 months
|
Quality of Life /Mental functioning)
Time Frame: Change from baseline to 3, 6 months
|
The 36-Item Short Form Health Survey (SF-36) subdomains of mental functioning, transformed score 0-100
|
Change from baseline to 3, 6 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The Pain Attitudes and Beliefs Scale for Physiotherapists (PABS-PT)
Time Frame: Change from before course participation to 4 months
|
Clinician reported 19-item scale.
Two subscales: biomedical orientation and behavioural orientation are scored
|
Change from before course participation to 4 months
|
Practitioner Confidence Scale (PCS)
Time Frame: Change from before course participation to 4 months
|
Clinician reported 4-item scale plus two items added to capture confidence about using a behavioral pain model
|
Change from before course participation to 4 months
|
The Determinants of Implementation Behavior Questionnaire (DIBQ)
Time Frame: Immediately after curse participation and 4 months
|
Clinician level measure of the implementation process.
Thirty-one items from the domains of knowledge, skills, beliefs about capability, beliefs about consequences, innovation, patients, intentions, organisation, social influences, social context, behavioural regulation, and innovation strategy
|
Immediately after curse participation and 4 months
|
Adoption
Time Frame: Within 6 months
|
Proportion of clinicians participating in a GLA:D Back course that delivers the program
|
Within 6 months
|
Patients participation
Time Frame: 4 months
|
Clinician reported proportion of invited patients who decide to participate
|
4 months
|
Patient compliance
Time Frame: 3 months
|
Proportion of patients enrolled in GLA:D Back that complete the program
|
3 months
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Alice Kongsted, PhD, University of Southern Denmark
Publications and helpful links
General Publications
- Kjaer P, Kongsted A, Ris I, Abbott A, Rasmussen CDN, Roos EM, Skou ST, Andersen TE, Hartvigsen J. GLA:D(R) Back group-based patient education integrated with exercises to support self-management of back pain - development, theories and scientific evidence. BMC Musculoskelet Disord. 2018 Nov 29;19(1):418. doi: 10.1186/s12891-018-2334-x.
- Kongsted A, Ris I, Kjaer P, Vach W, Morso L, Hartvigsen J. GLA:D(R) Back: implementation of group-based patient education integrated with exercises to support self-management of back pain - protocol for a hybrid effectiveness-implementation study. BMC Musculoskelet Disord. 2019 Feb 18;20(1):85. doi: 10.1186/s12891-019-2443-1.
- Ris I, Boyle E, Myburgh C, Hartvigsen J, Thomassen L, Kongsted A. Factors influencing implementation of the GLA:D Back, an educational/exercise intervention for low back pain: a mixed-methods study. JBI Evid Implement. 2021 May 10;19(4):394-408. doi: 10.1097/XEB.0000000000000284.
- Morso L, Bogh SB, Ris I, Kongsted A. Mind the gap - Evaluation of the promotion initiatives for implementation of the GLA:D(R) back clinician courses. Musculoskelet Sci Pract. 2021 Jun;53:102373. doi: 10.1016/j.msksp.2021.102373. Epub 2021 Mar 27.
- Ris I, Broholm D, Hartvigsen J, Andersen TE, Kongsted A. Adherence and characteristics of participants enrolled in a standardised programme of patient education and exercises for low back pain, GLA:D(R) Back - a prospective observational study. BMC Musculoskelet Disord. 2021 May 22;22(1):473. doi: 10.1186/s12891-021-04329-y.
- Joern L, Kongsted A, Thomassen L, Hartvigsen J, Ravn S. Pain cognitions and impact of low back pain after participation in a self-management program: a qualitative study. Chiropr Man Therap. 2022 Feb 21;30(1):8. doi: 10.1186/s12998-022-00416-6.
- Nim CG, Kongsted A, Downie A, Vach W. Temporal stability of self-reported visual back pain trajectories. Pain. 2022 Nov 1;163(11):e1104-e1114. doi: 10.1097/j.pain.0000000000002661. Epub 2022 Apr 25.
- Kongsted A, Hartvigsen J, Boyle E, Ris I, Kjaer P, Thomassen L, Vach W. GLA:D(R) Back: group-based patient education integrated with exercises to support self-management of persistent back pain - feasibility of implementing standardised care by a course for clinicians. Pilot Feasibility Stud. 2019 May 9;5:65. doi: 10.1186/s40814-019-0448-z. eCollection 2019.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- DPA 2015-57-0008 SDU 17/30591
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Back Pain, Low
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
Faculdade de Ciências Médicas da Santa Casa de...CompletedLow Back Pain, Mechanical | Low Back Pain, Postural | Lower Back Pain Chronic | Low Back Pain, Posterior CompartmentBrazil
-
University School of Physical Education in WroclawCompletedLow Back Pain | Low Back Pain, Mechanical | Low Back Pain, PosturalPoland
-
Texas Woman's UniversityTexas Physical Therapy AssociationCompletedLow Back Pain | Chronic Low Back Pain | Subacute Low Back PainUnited States
-
University of ParmaKing's College London; Helmholtz Zentrum München; GENOS; Ip Research Consulting... and other collaboratorsUnknownChronic Low Back Pain | Acute Low Back PainUnited States, Australia, Belgium, Croatia, Italy, United Kingdom
-
Ache Laboratorios Farmaceuticos S.A.Unknown
-
Palmer College of ChiropracticDepartment of Health and Human ServicesCompletedChronic Low Back Pain | Subacute Low Back PainUnited States
-
Universität Duisburg-EssenSiemens-BetriebskrankenkasseCompletedChronic Low Back Pain | Recurrent Low Back Pain
-
Karolinska InstitutetCompletedChronic Low Back Pain | Recurrent Low Back Pain | Persistent Low Back PainSweden
-
Apsen Farmaceutica S.A.CompletedLow Back Pain | Low Back Pain, Mechanical | Acute Low Back PainBrazil
Clinical Trials on GLA:D Back
-
Aileen DavisSunnybrook Health Sciences Centre; University of Southern Denmark; Arthritis... and other collaboratorsCompleted
-
University of AlbertaMcCaig Institute for Bone and Joint HealthCompleted
-
Hospital of South West JutlandOdense University HospitalCompletedChronic Pain | Osteoarthritis, KneeDenmark
-
Marshall UniversityUniversity of Toronto; University of Southern DenmarkRecruitingOsteoarthritis, KneeUnited States
-
University of Colorado, DenverNational Heart, Lung, and Blood Institute (NHLBI)RecruitingAsthma in ChildrenUnited States
-
Dallas VA Medical CenterAspen Medical ProductsCompletedLow Back Pain | Degenerative Disc Disease | Lumbar Spondylosis
-
Johns Hopkins UniversityRecruitingBack Pain | Low Back PainUnited States
-
Cleveland Clinic FloridaIntegral Orthopedics Inc.CompletedLow Back PainUnited States
-
Soonchunhyang University HospitalCompleted